Genitourinary Syndrome of Menopause
Cross-source consensus on Genitourinary Syndrome of Menopause from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Comparisons
Evidence quality
Highlighted claims
- With aging, childbirth, and hormonal decline, vaginal tissue thins and flattens, reducing elasticity and lubrication. — Women's Sexual Health, Menopause, and Integrated Care
- Stress urinary incontinence occurs when bladder pressure exceeds urethral pressure, often triggered by physical activity or sudden exertion. — Women's Sexual Health, Menopause, and Integrated Care
- CO2 vaginal laser therapy works by creating a controlled injury pattern that prompts the body to produce new collagen, elastin, and blood flow. — Women's Sexual Health, Menopause, and Integrated Care
- Health Canada has approved CO2 laser therapy for both GSM and stress urinary incontinence, while FDA clearance in the United States is more limited. — Women's Sexual Health, Menopause, and Integrated Care
- CO2 laser therapy provides an important non-hormonal option for patients who cannot use hormones due to cancer, stroke, or other contraindications. — Women's Sexual Health, Menopause, and Integrated Care
- ACOG has issued cautionary statements about vaginal lasers, and realistic patient expectations should be improvement rather than full tissue restoration. — Women's Sexual Health, Menopause, and Integrated Care